Clinical Trial Update: Efficacy and Safety of VA106483 in Elderly Males [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports efficacy and safety data for VA106483 in elderly males with nocturia across Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• VA106483

Snippet

Sponsor: Vantia Ltd | Conditions: Nocturia | Phase 1, Phase 2 | Status: COMPLETED